Conotruncal Cardiac Defects and Nutrigenetic Etiopathogeny

Conotruncal Cardiac Defects and Metabolism, Nutrigenetic Factors of Etiopathogeny of Conotruncal Cardiac Defects

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01460316

Acronym

CCOMET

Enrollment

400

Registered

2011-10-26

Start date

2011-10-31

Completion date

Unknown

Last updated

2016-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conotruncal Cardiac Defects

Keywords

Conotruncal cardiac defects, methylation, genotype, cobalamin, folates, nutrition

Brief summary

The investigators planned to study the etiopathogenic factors of conotruncal cardiac defects regarding the relations between the metabolic, the genetic and the environmental factors which lead to these cardiopathy.

Interventions

BIOLOGICALBood sampling for biochemicals and genetic analysis

There will be one blood sampling for the nutritionnal, metabolic and genetic parameters studied in the protocol

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Months to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Conotruncal cardiac defects patients and theirs mothers * Weight: \> 3750 g

Exclusion criteria

* Syndromic conotruncal cardiac defects * 22q11 deletion Holder's * Patients whose mother's took anti-folates before and during first pregnancy semester

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026